In Episode Three of the All Things Biosimilar Podcast: 

We hand out stuffing and peas across products, manufacturers, markets and others- and share our 2c on impact FDA guidance updates may have on the competitive landscape. Happy Thanksgiving!

00:00 Introduction and Thanksgiving Greetings

01:40 2025 Stuffing and Peas: Products

04:22 2025 Stuffing and Peas: Manufacturers

06:32 2025 Stuffing and Peas: Markets

10:36 2025 Stuffing and Peas: Other Category

13:36 FDA Regulations and Biosimilar Market Impact

28:47 Final Words and Gratitude

Connect with us!

Website:
www.Bourgoininsightsgroup.com

LinkedIn:
https://www.linkedin.com/company/bourgoin-insights-group

Disclaimer:

Bourgoin Insights Group, LLC publishes market intelligence reports on various Biosimilars, Biologics, and the U.S. Biosimilar industry. All reports, both published publicly and those provided pursuant to part of a subscription to All Things Biosimilar are subject to the following disclaimer. A subscription to All Things Biosimilar automatically indicates acceptance of the disclaimer.

We, at Bourgoin Insights Group, LLC, gather information from various sources such paid databases, published reports, FDA databases, annual reports, surveys and media releases. This public information is collated in good faith in preparation of analysis and used on an as is and as available basis by us.

Connect with us!

Website:
www.Bourgoininsightsgroup.com

LinkedIn:
https://www.linkedin.com/company/bourgoin-insights-group

Music:
Bang Boom - Captain Joz

Production:
Maine Frame

Disclaimer:

Bourgoin Insights Group, LLC publishes market intelligence reports on various Biosimilars, Biologics, and the U.S. Biosimilar industry. All reports, both published publicly and those provided pursuant to part of a subscription to All Things Biosimilar are subject to the following disclaimer. A subscription to All Things Biosimilar automatically indicates acceptance of the disclaimer.

We, at Bourgoin Insights Group, LLC, gather information from various sources such paid databases, published reports, FDA databases, annual reports, surveys and media releases. This public information is collated in good faith in preparation of analysis and used on an as is and as available basis by us.

In Episode Two of the All Things Biosimilar Podcast: 

Biosimilars and Total Addressable Market Analysis, U.S. Retina Market Dynamics, Q3 Earnings Season Preview 

00:00 Introduction and Episode Overview 
01:47 Feedback from Episode One 
02:36 Topic 1: Understanding TAM in Biosimilars 
05:51 Case Study: Coherus and TAM Analysis 
07:21 Detailed Market Analysis: Remicade, Herceptin, and Lucentis 
18:08 Portfolio Analysis and Future Projections 
24:04 Applying TAM Scenarios to Companies 
28:03 Analyzing Biosimilar Market Performance 
29:31 Exploring the US Retina Market 
30:54 Competitive Landscape for Aflibercept Biosimilars 
35:51 Upcoming Biosimilar Market Activities 
40:09 Earnings Season Preview: Key Questions and Topics 
43:15 Company-Specific Earnings Insights 
52:55 Conclusion and Upcoming Episodes

Connect with us!

Website:
www.Bourgoininsightsgroup.com

LinkedIn:
https://www.linkedin.com/company/bourgoin-insights-group

Music:
Bang Boom - Captain Joz

Production:
Maine Frame

Disclaimer:

Bourgoin Insights Group, LLC publishes market intelligence reports on various Biosimilars, Biologics, and the U.S. Biosimilar industry. All reports, both published publicly and those provided pursuant to part of a subscription to All Things Biosimilar are subject to the following disclaimer. A subscription to All Things Biosimilar automatically indicates acceptance of the disclaimer.

We, at Bourgoin Insights Group, LLC, gather information from various sources such paid databases, published reports, FDA databases, annual reports, surveys and media releases. This public information is collated in good faith in preparation of analysis and used on an as is and as available basis by us.

In Episode One of the All Things Biosimilar Podcast:

U.S. Ustekinumab Biosimilars Market YTD
U.S. Biosimilars Market Survey: Who Do You Think Will Be Leading the Next Decade?
Zarxio Turns 10

Chapters: 
00:00 Introduction to the Episode One
01:07 Big Topic 1: US Stelara Biosimilars Market
08:11 Big Topic 2:  Survey Results: Top Biosimilar Companies
11:05 Big Topic 3: Zarxio Turns 10

Connect with us!

Website:
www.Bourgoininsightsgroup.com

LinkedIn:
https://www.linkedin.com/company/bourgoin-insights-group

Music:
Bang Boom - Captain Joz

Production:
Maine Frame

Disclaimer:

Bourgoin Insights Group, LLC publishes market intelligence reports on various Biosimilars, Biologics, and the U.S. Biosimilar industry. All reports, both published publicly and those provided pursuant to part of a subscription to All Things Biosimilar are subject to the following disclaimer. A subscription to All Things Biosimilar automatically indicates acceptance of the disclaimer.

We, at Bourgoin Insights Group, LLC, gather information from various sources such paid databases, published reports, FDA databases, annual reports, surveys and media releases. This public information is collated in good faith in preparation of analysis and used on an as is and as available basis by us.

Connect with us!

Website:
www.Bourgoininsightsgroup.com

LinkedIn:
https://www.linkedin.com/company/bourgoin-insights-group

Music:
Bang Boom - Captain Joz

Production:
Maine Frame

Disclaimer:

Bourgoin Insights Group, LLC publishes market intelligence reports on various Biosimilars, Biologics, and the U.S. Biosimilar industry. All reports, both published publicly and those provided pursuant to part of a subscription to All Things Biosimilar are subject to the following disclaimer. A subscription to All Things Biosimilar automatically indicates acceptance of the disclaimer.

We, at Bourgoin Insights Group, LLC, gather information from various sources such paid databases, published reports, FDA databases, annual reports, surveys and media releases. This public information is collated in good faith in preparation of analysis and used on an as is and as available basis by us.